Prichard Mark N, Kern Earl R, Quenelle Debra C, Keith Kathy A, Moyer Richard W, Turner Peter C
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL 35233, USA.
Virol J. 2008 Mar 5;5:39. doi: 10.1186/1743-422X-5-39.
The vaccinia virus (VV) F2L gene encodes a functional deoxyuridine triphosphatase (dUTPase) that catalyzes the conversion of dUTP to dUMP and is thought to minimize the incorporation of deoxyuridine residues into the viral genome. Previous studies with with a complex, multigene deletion in this virus suggested that the gene was not required for viral replication, but the impact of deleting this gene alone has not been determined in vitro or in vivo. Although the crystal structure for this enzyme has been determined, its potential as a target for antiviral therapy is unclear.
The F2L gene was replaced with GFP in the WR strain of VV to assess its effect on viral replication. The resulting virus replicated well in cell culture and its replication kinetics were almost indistinguishable from those of the wt virus and attained similar titers. The virus also appeared to be as pathogenic as the WR strain suggesting that it also replicated well in mice. Cells infected with the dUTPase mutant would be predicted to affect pyrimidine deoxynucleotide pools and might be expected to exhibit altered susceptibility to pyrimidine analogs. The antiviral activity of cidofovir and four thymidine analogs were evaluated both in the mutant and the parent strain of this virus. The dUTPase knockout remained fully susceptible to cidofovir and idoxuridine, but was hypersensitive to the drug (N)-methanocarbathymidine, suggesting that pyrimidine metabolism was altered in cells infected with the mutant virus. The absence of dUTPase should reduce cellular dUMP pools and may result in a reduced conversion to dTMP by thymidylate synthetase or an increased reliance on the salvage of thymidine by the viral thymidine kinase.
We confirmed that F2L was not required for replication in cell culture and determined that it does not play a significant role on virulence of the virus in intranasally infected mice. The recombinant virus is hypersensitive to (N)-methanocarbathymidine and may reflect metabolic differences in the mutant virus.
痘苗病毒(VV)F2L基因编码一种功能性脱氧尿苷三磷酸酶(dUTPase),该酶催化dUTP转化为dUMP,被认为可使脱氧尿苷残基掺入病毒基因组的情况降至最低。此前对该病毒复杂多基因缺失的研究表明,该基因对于病毒复制并非必需,但单独删除该基因在体外或体内的影响尚未确定。尽管已确定该酶的晶体结构,但其作为抗病毒治疗靶点的潜力尚不清楚。
在VV的WR株中用绿色荧光蛋白(GFP)取代F2L基因,以评估其对病毒复制的影响。所得病毒在细胞培养中复制良好,其复制动力学与野生型病毒几乎无法区分,且达到了相似的滴度。该病毒似乎与WR株一样具有致病性,表明它在小鼠体内也能很好地复制。预计感染dUTPase突变体的细胞会影响嘧啶脱氧核苷酸库,并且可能表现出对嘧啶类似物的敏感性改变。在该病毒的突变体和亲本株中均评估了西多福韦和四种胸苷类似物的抗病毒活性。dUTPase基因敲除病毒对西多福韦和碘苷仍完全敏感,但对药物(N)-甲氧基卡巴胸苷高度敏感,这表明感染突变病毒的细胞中嘧啶代谢发生了改变。dUTPase的缺失应会减少细胞内dUMP库,并可能导致胸苷酸合成酶将其转化为dTMP的过程减少,或者增加病毒胸苷激酶对胸苷补救途径的依赖。
我们证实F2L在细胞培养中并非复制所必需,并确定它在鼻内感染小鼠中对病毒毒力没有显著作用。重组病毒对(N)-甲氧基卡巴胸苷高度敏感,这可能反映了突变病毒的代谢差异。